SEARCH

SEARCH BY CITATION

References

  • Benet, I., Terol, M.J., Marugan, I., Martinez-Climent, J.A., Sarsotti, E., Ivars, C., Prosper, F., Vizcarra, E., Marco, J., Martinez, J., De Miguel, A., Ortuno, F., Garcia, M., Monteagud, M., Garcia, R. & Garcia-Conde, J. (2000) CD38 expression definesclinical and biological characteristics in B-CLL. Blood, 96, 371a.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Violitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiovazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia. Blood, 94, 18401847.
  • Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Del Moro, B., Suppo, G., Epiceno, A.M., Del Principe, M.I., Masi, M. & Amadori, S. (2000) CD38 expression identifies two distinct prognostic subsets in B-chronic lymphocytic leukaemia (B-CLL). Blood, 96, 366a.
  • Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M.I., Del Moro, B., Masi, M. & Amadori, S. (2001) Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood, 98, 26332639.
  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, Jr, C.A. & Miller, T.P. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 10021006.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood, 94, 18481864.
  • Hamblin, T.J., Davis, Z., Orchard, J.A., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, 2455.
  • Ibrahim, S., Keating, M., Do, K.-A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. & Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukaemia. Blood, 96, 181186.
  • Kennedy, B.J., Broomfield, C.D., Kiang, D.T., Vosika, K., Peterson, B.A. & Theologides, A. (1978) Combination versus successive single agent chemotherapy in lymphocytic lymphoma. Cancer, 41, 2328.
  • Keyhani, A., Huh, Y.O. & Jendiroba, D. (1999) Increased CD38 expression is associated with favourable prognosis in adult acute leukemia. Leukemia Research, 24, 153159.DOI: 10.1016/S0145-2126(99)00147-2
  • Kumagai, M., Coustan-Smith, E., Murry, D.J., Silvennoinen, O., Murti, G.P., Evans, W.E., Malavasi, M. & Campana, D. (1995) Ligation of CD38 suppresses human B lymphopoiesis. Journal of Experimental Medicine, 181, 11011110.
  • Malavasi, F., Funaro, A., Roggereo, S., Horenstein, A., Calosso, L. & Mehta, K. (1994) Human CD38: a plycoprotein in research of a function. Immunology Today, 15, 9597.
  • Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R. & Cawley, J.C. (2001) CD38 expression and IgVH gene mutation in B-cell chronic lymphocytic leukaemia. Blood, 97, 19021903.
  • Metha, K., Shahid, U. & Malavasi, F. (1996) Human CD38, a cell-surface protein with multiple functions. FASEB Journal, 10, 14081417.
  • O'Brien, S., Del Giglio, A. & Keating, M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukaemia. Blood, 85, 307318.
  • Oertel, J., Oertel, B., Schliecher, J. & Huhn, D. (1996) Immunophenotyping of blasts in human bone marrow. Annals in Hematology, 72, 125129.
  • Omede, P., Boccadoro, M., Gallone, G., Frieri, R., Battaglio, S., Redoglia, V. & Pileri, A. (1990) Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor prognosis. Blood, 76, 13751379.
  • Reinherz, E.L., Kung, P.C., Goldstein, G., Kumagai, M., Coustan-Smith, E. & Murry, D.J. (1980) Discrete stages of intrathymic differentiation: analysis of normal thymocytes and leukaemic lymphoblasts of T lineage. Proceedings of the National Academy of Sciences of the United States of America, 77, 15881592.
  • Santos-Argumedo, L., Teixeira, C., Preece, G., Kirkham, P.A. & Parkhouse, R.M.E. (1993) A B-lymphocyte surface molecule medicating activation and protection from apoptosis via calcium channels. Journal of Immunology, 151, 31193130.
  • Thunberg, U., Johnson, A., Roos, G., Thom, I., Tobing, G., Sallstrom, J., Sundstrom, C. & Rosenquist, R. (2001) CD38 expression is a poor predictor of VH gene mutational status andprognosis in chronic lymphocytic leukaemia. Blood, 97, 18921893.
  • Zupo, S., Rugari, E., Dono, M., Tamborelli, G., Malavasi, F. & Ferrarini, M. (1994) CD38 signalling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cellls. European Journal of Immunology, 24, 12181222.
  • Zupo, S., Isnardi, L., Megna, M., Malavasi, F., Dono, M., Cosolich, E. & Ferrarini, M. (1996) CD38 Expression distinguishes two groups of B-cell chronic lymphocytic leukaemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood, 88, 13651374.
  • Zwiebel, J.A. & Cheson, B.D. (1998) Chronic lymphocytic leukaemia: staging and prognostic factors. Seminars in Oncology, 25, 4259.